297 related articles for article (PubMed ID: 5496795)
1. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
Hétrick G; Muñoz I; Ras R
Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
[No Abstract] [Full Text] [Related]
2. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
3. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Mkrtchian SV; Ushkin VV
Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
[No Abstract] [Full Text] [Related]
4. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
5. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
[No Abstract] [Full Text] [Related]
6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
7. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Virsik K; Kruty R; Matula F; Badalik L
Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
[No Abstract] [Full Text] [Related]
8. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
9. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
10. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
[TBL] [Abstract][Full Text] [Related]
11. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
12. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Grumbach F
Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
[No Abstract] [Full Text] [Related]
13. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Meissner G
Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
[No Abstract] [Full Text] [Related]
14. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Somner AR; Selkon JB; Walton M; White AB
Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
[No Abstract] [Full Text] [Related]
15. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
Anastasatu C; Sibila S
Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
[No Abstract] [Full Text] [Related]
16. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
[No Abstract] [Full Text] [Related]
17. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
18. [Internal medicine treatment of pulmonary tuberculosis].
Schaich W
Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
[No Abstract] [Full Text] [Related]
19. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
20. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
Homenko AG; Ciukanov VL
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
